Clinical trial
Treatment of Adolescent Suicide Attempters (TASA)
NCT00080158 · New York State Psychiatric Institute, Other · Completed
Key facts
| NCT number | NCT00080158 |
|---|---|
| Title | Treatment of Adolescent Suicide Attempters (TASA) |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Depression, Suicide, Attempted |
| Intervention type | Behavioral, Drug |
| Interventions | fluoxetine, sertraline, citalopram, escitalopram, bupropion, mirtazapine, venlafaxine, lithium, Cognitive Behavioral Therapy |
| Enrollment | 120 |
| Start date | Mar 1, 2004 |
| Completion | Jun 1, 2007 |
| First posted | Mar 26, 2004 |
| Last update posted | Jun 22, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: